Advances in acute and preventive treatment of migraine
Abstract
Migraine is a common and often disabling neurologic disease, its high prevalence and disability significantly impact on patients and relatives, contributing to heavy social and economic burden. However, currently available migraine treatment options are limited and are often associated with many intolerable sideeffects. Therefore, it is necessary to explore new therapeutic options for migraine. This review discusses the most recent and evidencebased advances in pharmacological and nonpharmacological treatment approaches for migraine.
doi:10.3969/j.issn.16726731.2022.02.007
Keywords
Migraine; Drug therapy; Serotonin receptor agonists; Calcitonin generelated peptide; Pituitary adenylate cyclaseactivating polypeptide; Antibodies, monoclonal; Acupuncture therapy; Review
This work is licensed under a Creative Commons Attribution 3.0 License.